Drug profile · INN
mepolizumab
BOSATRIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
mepolizumab (BOSATRIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN mepolizumab
Brand BOSATRIA
Route SUBCUTANEOUS
Formulation INJECTABLE
ATC code R03DX09
Frequently asked questions
What is mepolizumab?
mepolizumab (BOSATRIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for mepolizumab?
BOSATRIA is a marketed brand name for mepolizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mepolizumab?
mepolizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.